BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30652073)

  • 41. miR-200b suppresses cell growth, migration and invasion by targeting Notch1 in nasopharyngeal carcinoma.
    Yang X; Ni W; Lei K
    Cell Physiol Biochem; 2013; 32(5):1288-98. PubMed ID: 24281414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of lncRNA ZFAS1 inhibits progression of nasopharyngeal carcinoma by sponging miR-135a.
    Wang M; Ji YQ; Song ZB; Ma XX; Zou YY; Li XS
    Neoplasma; 2019 Nov; 66(6):939-945. PubMed ID: 31307201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.
    Qi X; Li J; Zhou C; Lv C; Tian M
    FEBS Lett; 2014 Oct; 588(20):3732-8. PubMed ID: 25171860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H; Lv W; Sun W; Bi Q; Hao Y
    Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
    Yu BL; Peng XH; Zhao FP; Liu X; Lu J; Wang L; Li G; Chen HH; Li XP
    Int J Oncol; 2014 Apr; 44(4):1215-22. PubMed ID: 24481647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.
    Zhang Y; Wang SS; Tao L; Pang LJ; Zou H; Liang WH; Liu Z; Guo SL; Jiang JF; Zhang WJ; Jia W; Li F
    Sci Rep; 2019 Jun; 9(1):8401. PubMed ID: 31182739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.
    Fan Y; Ge N; Wang X; Sun W; Mao R; Bu W; Creighton CJ; Zheng P; Vasudevan S; An L; Yang J; Zhao YJ; Zhang H; Li XN; Rao PH; Leung E; Lu YJ; Gray JW; Schiff R; Hilsenbeck SG; Osborne CK; Yang J; Zhang H
    J Pathol; 2014 Jan; 232(1):75-86. PubMed ID: 24122835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-646 inhibits proliferation and cell cycle progression of nasopharyngeal carcinoma cells by targeting mTOR.
    Song YL; Pan MZ; Wang AL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8905-8912. PubMed ID: 31696477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
    Lv LY; Wang YZ; Zhang Q; Zang HR; Wang XJ
    Cell Biochem Funct; 2015 Dec; 33(8):534-40. PubMed ID: 26559153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
    Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
    Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
    Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
    J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.
    Duan HF; Li XQ; Hu HY; Li YC; Cai Z; Mei XS; Yu P; Nie LP; Zhang W; Yu ZD; Nie GH
    Tumour Biol; 2015 Sep; 36(9):6679-89. PubMed ID: 25809707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.